bpc-157 human clinical trials evidence review safety regulatory status Gastric pentadecapeptide body protection compound BPC bpc-157 human clinical trials evidence

Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies

Systemic subcutaneous injections are highly effective and much safer, avoiding the complex network of nerves and vessels within the muscle

DSIP modulates sleep-promoting pathways rather than inducing acute sedation

doi: 10.1056/NEJMra1011040

Gastrointestinal Research Studies Laboratory studies show BPC-157 exhibits gastroprotective effects through modulation of inflammatory pathways and enhancement of mucosal defense mechanisms in various GI research models

InfiniWell BPC-157 500 mcg Pro Delayed Release Ingredients: InfiniWell BPC-157 500 mcg Pro Delayed Release Ingredients: Serving Size: 1 Capsule Body Protective Compound (as BPC-157 Arginate Salt) 500 mcg Salcaprozate Sodium (SNAC) 3 mg Other Ingredients: Rice Powder, Microcrystalline Cellulose, Vegetable Capsule (Hypromellose, Gellan Gum) Delayed-Release Capsules, Gluten Free, Dairy Free, Soy Free, Non-GMO Warnings: If pregnant, nursing, or taking prescription drugs, consult your healthcare professional prior to use.